Drugs like Ozempic and Mounjaro are GLP-1-based medications, meaning they mimic gut hormones that help regulate appetite and ...

Rite Aid, the U.S. pharmacy chain, is reportedly weighing another Chapter 11 bankruptcy filing after its recent financial ...

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Recursion Pharmaceuticals (RXRX – Research ...

Analysts fell to the sidelines weighing in on Keros Therapeutics (KROS – Research Report) and Illumina (ILMN – Research Report) with neutral ...

WeightWatchers has stood as a source of hope for millions seeking to shed pounds through community support, disciplined ...

The nomination of Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS) has ignited considerable debate.

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

Current list price: A 1-month supply of Imcivree starts at $3,623.40 and varies by pharmacy ... If you’ve tried everything to lose weight and the scale won’t budge, it’s worth talking ...

Which bills lived or died after the Iowa Legislature's second "funnel" deadline on Friday? Check out the complete list.

It's difficult to see upside for stocks when pessimism is pervasive, but as investors were reminded in 2022, buying shares of growing companies amid fear on Wall Street can earn you monster returns ...